BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32192732)

  • 1. Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer.
    Betella I; Turbitt WJ; Szul T; Wu B; Martinez A; Katre A; Wall JA; Norian L; Birrer MJ; Arend R
    Gynecol Oncol; 2020 Jun; 157(3):765-774. PubMed ID: 32192732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
    Arend R; Dholakia J; Castro C; Matulonis U; Hamilton E; Jackson CG; LyBarger K; Goodman HM; Duska LR; Mahdi H; ElNaggar AC; Kagey MH; Liu A; Piper D; Barroilhet LM; Bradley W; Sachdev J; Sirard CA; O'Malley DM; Birrer M
    Gynecol Oncol; 2023 May; 172():82-91. PubMed ID: 37001446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy.
    Wall JA; Meza-Perez S; Scalise CB; Katre A; Londoño AI; Turbitt WJ; Randall T; Norian LA; Arend RC
    Gynecol Oncol; 2021 Jan; 160(1):285-294. PubMed ID: 33168307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-DKK1 antibody DKN-01 as an immunomodulatory combination partner for the treatment of cancer.
    Wall JA; Klempner SJ; Arend RC
    Expert Opin Investig Drugs; 2020 Jul; 29(7):639-644. PubMed ID: 32408777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance.
    Dholakia J; Scalise CB; Katre AA; Goldsberry WN; Meza-Perez S; Randall TD; Norian LA; Novak L; Arend RC
    Gynecol Oncol; 2022 Jan; 164(1):170-180. PubMed ID: 34844776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment.
    Haas MS; Kagey MH; Heath H; Schuerpf F; Rottman JB; Newman W
    Mol Cancer Res; 2021 Apr; 19(4):717-725. PubMed ID: 33443105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01.
    Jarman EJ; Horcas-Lopez M; Waddell SH; MacMaster S; Gournopanos K; Soong DYH; Musialik KI; Tsokkou P; Ng ME; Cambridge WA; Wilson DH; Kagey MH; Newman W; Pollard JW; Boulter L
    Liver Int; 2023 Jan; 43(1):208-220. PubMed ID: 35924447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment.
    Goldsberry WN; Meza-Perez S; Londoño AI; Katre AA; Mott BT; Roane BM; Goel N; Wall JA; Cooper SJ; Norian LA; Randall TD; Birrer MJ; Arend RC
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32213921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer.
    Wise DR; Schneider JA; Armenia J; Febles VA; McLaughlin B; Brennan R; Thoren KL; Abida W; Sfanos KS; De Marzo AM; Yegnasubramanian S; Fox JJ; Haas M; Heath H; Kagey MH; Newman W; Sirard CA; Fleisher M; Morris MJ; Chen Y; Larson SM; Haffner MC; Nelson PS; Schultz N; Garabedian MJ; Scher HI; Logan SK; Sawyers CL;
    JCO Precis Oncol; 2020; 4():. PubMed ID: 33015525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
    Zhu J; Zhang S; Gu L; Di W
    Carcinogenesis; 2012 Dec; 33(12):2334-43. PubMed ID: 22964660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dickkopf-1: A Promising Target for Cancer Immunotherapy.
    Chu HY; Chen Z; Wang L; Zhang ZK; Tan X; Liu S; Zhang BT; Lu A; Yu Y; Zhang G
    Front Immunol; 2021; 12():658097. PubMed ID: 34093545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).
    Wise DR; Pachynski RK; Denmeade SR; Aggarwal RR; Deng J; Febles VA; Balar AV; Economides MP; Loomis C; Selvaraj S; Haas M; Kagey MH; Newman W; Baum J; Troxel AB; Griglun S; Leis D; Yang N; Aranchiy V; Machado S; Waalkes E; Gargano G; Soamchand N; Puranik A; Chattopadhyay P; Fedal E; Deng FM; Ren Q; Chiriboga L; Melamed J; Sirard CA; Wong KK
    Prostate Cancer Prostatic Dis; 2024 Feb; ():. PubMed ID: 38341461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
    Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
    Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DKK1 Promotes Tumor Immune Evasion and Impedes Anti-PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer.
    Shi T; Zhang Y; Wang Y; Song X; Wang H; Zhou X; Liang K; Luo Y; Che K; Wang X; Pan Y; Liu F; Yang J; Liu Q; Yu L; Liu B; Wei J
    Cancer Immunol Res; 2022 Dec; 10(12):1506-1524. PubMed ID: 36206576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling.
    Wang B; Liu J; Ma LN; Xiao HL; Wang YZ; Li Y; Wang Z; Fan L; Lan C; Yang M; Hu L; Wei Y; Bian XW; Chen D; Wang J
    J Gastroenterol; 2013 Jul; 48(7):798-808. PubMed ID: 23188090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
    Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
    Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dickkopf-1, the Wnt antagonist, is induced by acidic pH and mediates epithelial cellular senescence in human reflux esophagitis.
    Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Schmidt J; Mackinnon A; Venu N; Shaker R
    Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G557-74. PubMed ID: 24481601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Sost/Sclerostin and Dickkopf-1 Augment Intervertebral Disc Structure in Mice.
    Kroon T; Bhadouria N; Niziolek P; Edwards D; Choi R; Clinkenbeard EL; Robling A; Holguin N
    J Bone Miner Res; 2022 Jun; 37(6):1156-1169. PubMed ID: 35278242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.